BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

906 related articles for article (PubMed ID: 24018051)

  • 1. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal effect of quercetin on multidrug resistance via FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Huang C; Ma T; Jiang L; Tang L; Shi T; Zhang S; Zhang L; Zhu P; Li J; Shen A
    Phytomedicine; 2018 Apr; 43():37-45. PubMed ID: 29747752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
    Lu F; Hou YQ; Song Y; Yuan ZJ
    Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w.
    Yang X; Yin J; Yu J; Xiang Q; Liu Y; Tang S; Liao D; Zhu B; Zu X; Tang H; Lei X
    Oncol Rep; 2012 Jan; 27(1):250-7. PubMed ID: 21947305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells.
    Yang T; Zheng ZM; Li XN; Li ZF; Wang Y; Geng YF; Bai L; Zhang XB
    Exp Biol Med (Maywood); 2013 Sep; 238(9):1024-32. PubMed ID: 23925649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
    Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
    Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor γ.
    Li S; Li J; Fei BY; Shao D; Pan Y; Mo ZH; Sun BZ; Zhang D; Zheng X; Zhang M; Zhang XW; Chen L
    Chin Med J (Engl); 2015 Apr; 128(7):941-7. PubMed ID: 25836616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
    Cao F; Yin LX
    Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
    Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
    Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II.
    Huang C; Xu D; Xia Q; Wang P; Rong C; Su Y
    J Pharm Pharmacol; 2012 Dec; 64(12):1741-50. PubMed ID: 23146037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
    Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
    Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line.
    Gu W; Fang FF; Li B; Cheng BB; Ling CQ
    Asian Pac J Cancer Prev; 2012; 13(9):4807-14. PubMed ID: 23167424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy.
    Yuan P; Cao W; Zang Q; Li G; Guo X; Fan J
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1067-73. PubMed ID: 27524242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-183 modulates multi-drug resistance in hepatocellular cancer (HCC) cells via miR-183-IDH2/SOCS6-HIF-1α feedback loop.
    Wang XJ; Zhang DL; Fu C; Wei BZ; Li GJ
    Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2020-7. PubMed ID: 27249600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
    Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
    Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-195 regulates cell apoptosis of human hepatocellular carcinoma cells by targeting LATS2.
    Yang X; Yu J; Yin J; Xiang Q; Tang H; Lei X
    Pharmazie; 2012 Jul; 67(7):645-51. PubMed ID: 22888524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing the EZH2 gene by RNA interference reverses the drug resistance of human hepatic multidrug-resistant cancer cells to 5-Fu.
    Zhang Y; Liu G; Lin C; Liao G; Tang B
    Life Sci; 2013 May; 92(17-19):896-902. PubMed ID: 23562851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of microRNA-1 on hepatocellular carcinoma tumor endothelial cells.
    Hu C; Shen SQ; Cui ZH; Chen ZB; Li W
    World J Gastroenterol; 2015 May; 21(19):5884-92. PubMed ID: 26019452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal effect of melanoma differentiation associated gene-7/interleukin-24 on multidrug resistance in human hepatocellular carcinoma cells.
    Fang P; Zhang X; Gao Y; Ding CR; Cui F; Jiao SC
    Anat Rec (Hoboken); 2012 Oct; 295(10):1639-46. PubMed ID: 22899557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.